These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26536628)

  • 1. Influence of the Lactotripeptides Isoleucine-Proline-Proline and Valine-Proline-Proline on Systolic Blood Pressure in Japanese Subjects: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Chanson-Rolle A; Aubin F; Braesco V; Hamasaki T; Kitakaze M
    PLoS One; 2015; 10(11):e0142235. PubMed ID: 26536628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do the lactotripeptides isoleucine-proline-proline and valine-proline-proline reduce systolic blood pressure in European subjects? A meta-analysis of randomized controlled trials.
    Cicero AF; Aubin F; Azais-Braesco V; Borghi C
    Am J Hypertens; 2013 Mar; 26(3):442-9. PubMed ID: 23382495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood pressure lowering effect of lactotripeptides assumed as functional foods: a meta-analysis of current available clinical trials.
    Cicero AF; Gerocarni B; Laghi L; Borghi C
    J Hum Hypertens; 2011 Jul; 25(7):425-36. PubMed ID: 20811398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactopeptides and human blood pressure.
    Geleijnse JM; Engberink MF
    Curr Opin Lipidol; 2010 Feb; 21(1):58-63. PubMed ID: 19884823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of the short-term effect of isoleucine-proline-proline/valine-proline-proline lactotripeptides from casein on office and ambulatory blood pressure in subjects with pharmacologically untreated high-normal blood pressure or first-degree hypertension.
    Cicero AF; Rosticci M; Ferroni A; Bacchelli S; Veronesi M; Strocchi E; Borghi C
    Clin Exp Hypertens; 2012; 34(8):601-5. PubMed ID: 22574612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactotripeptides show no effect on human blood pressure: results from a double-blind randomized controlled trial.
    Engberink MF; Schouten EG; Kok FJ; van Mierlo LA; Brouwer IA; Geleijnse JM
    Hypertension; 2008 Feb; 51(2):399-405. PubMed ID: 18086944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lactotripeptides do not lower ambulatory blood pressure in untreated whites: results from 2 controlled multicenter crossover studies.
    van Mierlo LA; Koning MM; van der Zander K; Draijer R
    Am J Clin Nutr; 2009 Feb; 89(2):617-23. PubMed ID: 19106238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of long-term intake of lactotripeptides on cardiovascular risk factors in hypertensive subjects.
    Jauhiainen T; Niittynen L; Orešič M; Järvenpää S; Hiltunen TP; Rönnback M; Vapaatalo H; Korpela R
    Eur J Clin Nutr; 2012 Jul; 66(7):843-9. PubMed ID: 22617279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lactotripeptides isoleucine-proline-proline and valine-proline-proline do not inhibit the N-terminal or C-terminal angiotensin converting enzyme active sites in humans.
    Wuerzner G; Peyrard S; Blanchard A; Lalanne F; Azizi M
    J Hypertens; 2009 Jul; 27(7):1404-9. PubMed ID: 19506528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Casein hydrolysate containing the antihypertensive tripeptides Val-Pro-Pro and Ile-Pro-Pro improves vascular endothelial function independent of blood pressure-lowering effects: contribution of the inhibitory action of angiotensin-converting enzyme.
    Hirota T; Ohki K; Kawagishi R; Kajimoto Y; Mizuno S; Nakamura Y; Kitakaze M
    Hypertens Res; 2007 Jun; 30(6):489-96. PubMed ID: 17664851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of the toxicological potential of tripeptides (L-valyl-L-prolyl-L-proline and L-isoleucyl-L-prolyI-L-proline): II. Introduction.
    Bernard BK; Nakamura Y; Bando I; Mennear JH
    Int J Toxicol; 2005; 24 Suppl 4():5-11. PubMed ID: 16419575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of long-term intake of milk products on blood pressure in hypertensive rats.
    Sipola M; Finckenberg P; Korpela R; Vapaatalo H; Nurminen ML
    J Dairy Res; 2002 Feb; 69(1):103-11. PubMed ID: 12047101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Lactotripeptides (Isoleucine-Proline-Proline/Valine-Proline-Proline) on Blood Pressure and Arterial Stiffness Changes in Subjects with Suboptimal Blood Pressure Control and Metabolic Syndrome: A Double-Blind, Randomized, Crossover Clinical Trial.
    Cicero AF; Colletti A; Rosticci M; Cagnati M; Urso R; Giovannini M; Borghi C; D'Addato S
    Metab Syndr Relat Disord; 2016 Apr; 14(3):161-6. PubMed ID: 26683986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Casein hydrolysate containing Val-Pro-Pro and Ile-Pro-Pro improves central blood pressure and arterial stiffness in hypertensive subjects: a randomized, double-blind, placebo-controlled trial.
    Nakamura T; Mizutani J; Ohki K; Yamada K; Yamamoto N; Takeshi M; Takazawa K
    Atherosclerosis; 2011 Nov; 219(1):298-303. PubMed ID: 21723554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term intake of milk peptides attenuates development of hypertension in spontaneously hypertensive rats.
    Sipola M; Finckenberg P; Santisteban J; Korpela R; Vapaatalo H; Nurminen ML
    J Physiol Pharmacol; 2001 Dec; 52(4 Pt 2):745-54. PubMed ID: 11785770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-dependent lowering of blood pressure by dairy peptides in mildly hypertensive subjects.
    de Leeuw PW; van der Zander K; Kroon AA; Rennenberg RM; Koning MM
    Blood Press; 2009; 18(1-2):44-50. PubMed ID: 19247842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactotripeptides intake and blood pressure management: a meta-analysis of randomised controlled clinical trials.
    Qin LQ; Xu JY; Dong JY; Zhao Y; van Bladeren P; Zhang W
    Nutr Metab Cardiovasc Dis; 2013 May; 23(5):395-402. PubMed ID: 23566677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial potential of casein hydrolysate containing Val-Pro-Pro and Ile-Pro-Pro on central blood pressure and hemodynamic index: a preliminary study.
    Nakamura T; Mizutani J; Sasaki K; Yamamoto N; Takazawa K
    J Med Food; 2009 Dec; 12(6):1221-6. PubMed ID: 19821692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive effects of bioactive tripeptides-a random effects meta-analysis.
    Turpeinen AM; Järvenpää S; Kautiainen H; Korpela R; Vapaatalo H
    Ann Med; 2013 Feb; 45(1):51-6. PubMed ID: 23305234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The blood pressure lowering effect of lactotripeptides and salt intake in 24-h ambulatory blood pressure measurements.
    Yamasue K; Morikawa N; Mizushima S; Tochikubo O
    Clin Exp Hypertens; 2010 Jul; 32(4):214-20. PubMed ID: 20608891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.